HCP Live

PODCAST: Gut check

April 1, 2015

Article

Among recent research on nonpharmacologic therapies for the often baffling sequelae accompanying autism, some of the most intriguing explores clues to its etiology. A.J. Russo, PhD, recently sat down exclusively with Contemporary Pediatrics to discuss his newly published study of how probiotics impact gut flora and biomarkers such as copper in children with autism-looking for their correlations with GI disease and behavioral symptom severity.

Among recent research on nonpharmacologic therapies for the often baffling sequelae accompanying autism, some of the most intriguing explores clues to its etiology. A.J. Russo, PhD, recently sat down exclusively with Contemporary Pediatrics to discuss his newly published study of how probiotics impact gut flora and biomarkers such as copper in children with autism-looking for their correlations with GI disease and behavioral symptom severity. Russo AJ. Decreased plasma myeloperoxidase associated with probiotic therapy in autistic children. Clin Med Insights Pediatr. 2015 Feb 3;9:13-17.

Find Dr. Russo's study here.

Recent Videos

Joshua Feder, MD

Zika-based therapy for metastatic neuroblastoma with Tamarah Westmoreland, MD and Joseph Mazar, PhD | Image Credit: © Nemours- © Nemours - stock.adobe.com.

Geetika Kennady, MD, FAAP

Jillian Cotter, MD

Jesse Hinckley, MD, PhD

Validating digital stethoscope for pediatric breath sounds, with Jennifer Nestor, MD

Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD

Sensory play for children with autism, with Joshua Feder, MD

Related Content

FDA seeks to remove ingestible fluoride products | Image credit: Contemporary Pediatrics

FDA seeks to remove ingestible fluoride products for children

Joshua Fitch, Senior Editor

The administration has set a goal date of October 31 to complete a safety review, public comment period, and to take "appropriate action" in efforts to remove products from the market.

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023

FDA approves pediatric indication for Optison ultrasound enhancing agent | Image credit: Contemporary Pediatrics

FDA approves pediatric indication for Optison ultrasound enhancing agent

Joshua Fitch, Senior Editor

This FDA decision will help to improve clarity and diagnostic accuracy of echocardiograms in pediatric patients, according to GE HealthCare.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022

FDA clears EN-374 therapy application for X-linked chronic granulomatous disease } Image credit: Contemporary Pediatrics

FDA clears EN-374 therapy application for X-linked chronic granulomatous disease

Joshua Fitch, Senior Editor

The in vivo hematopoietic stem cell-directed therapy received rare pediatric disease and orphan drug designations earlier this year.

Frequent perinatal antibiotic use and impaired lung function in preterm-born children | Image Credit: © greenapple78 - © greenapple78 - stock.adobe.com.

Frequent perinatal antibiotic use and impaired lung function in preterm-born children

Joshua Fitch, Senior Editor

"Early identification of high-risk neonates may enable targeted strategies to support respiratory health," stated the study investigators.

Related Content

FDA seeks to remove ingestible fluoride products | Image credit: Contemporary Pediatrics

FDA seeks to remove ingestible fluoride products for children

Joshua Fitch, Senior Editor

The administration has set a goal date of October 31 to complete a safety review, public comment period, and to take "appropriate action" in efforts to remove products from the market.

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023

FDA approves pediatric indication for Optison ultrasound enhancing agent | Image credit: Contemporary Pediatrics

FDA approves pediatric indication for Optison ultrasound enhancing agent

Joshua Fitch, Senior Editor

This FDA decision will help to improve clarity and diagnostic accuracy of echocardiograms in pediatric patients, according to GE HealthCare.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022

FDA clears EN-374 therapy application for X-linked chronic granulomatous disease } Image credit: Contemporary Pediatrics

FDA clears EN-374 therapy application for X-linked chronic granulomatous disease

Joshua Fitch, Senior Editor

The in vivo hematopoietic stem cell-directed therapy received rare pediatric disease and orphan drug designations earlier this year.

Frequent perinatal antibiotic use and impaired lung function in preterm-born children | Image Credit: © greenapple78 - © greenapple78 - stock.adobe.com.

Frequent perinatal antibiotic use and impaired lung function in preterm-born children

Joshua Fitch, Senior Editor

"Early identification of high-risk neonates may enable targeted strategies to support respiratory health," stated the study investigators.

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.